Kamran Qureshi, M.D.April 28, 2023

FDA 483 - Kamran Qureshi, M.D. - April 28, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kamran Qureshi, M.D.

Record Details

An FDA inspection of Kamran Qureshi, M.D. in Saint Louis, MO, identified a significant issue regarding the conduct of an investigation. The clinical investigator failed to maintain control and accountability for study drugs, specifically eleven missing study kits. This indicates a serious lapse in adherence to the investigational plan and regulatory requirements for drug management.

Company: Kamran Qureshi, M.D.
Inspection Date: April 28, 2023
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West II
Person: Carmen Y. Fisher

Open in Dashboard

ID · 9e902e79-e94d-4e14-bb08-3468473ee43d